Sequential Use of Propofol/Midazolam and Dexmedetomidine for Sedation in Mechenical Ventialtion Patients in ICU.
NCT02122055 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2014-04-24
Summary
For the patient who passed the screen of weaning from ventilation, the traditional sedation drug such as propofol and midazolam should be decreased or stopped, then it would induce the stress response and agitation, such as hypertension,tachycardia etc. In order to resolve that problem, the sedation should be given again. but if renewed to sedation, it would cause prolonged sedation and ventilation duration.
So as to resolve above issues, after the patient passed the screen of weaning, sedation is changed to Dexmedetomidine, a new sedation drug, that could wake up at any time. So our study to compare the efficacy and safety of sequential sedation of propofol or midazolam and dexmedetomidine in mechanical ventilated ICU patients.
Conditions
- Mechanical Ventilation Complication
Interventions
- DRUG
-
Fentanyl 0.7-1μg/kg,prn pain assessment is done every 4 hours,maintain Behavioral Pain Scale(BPS) 0-2.
- PROCEDURE
-
Sedation assessment
Sedation assessment is done every 4 hours,maintain the Riker Sedation Agitation Score(SAS) 3-4.
- PROCEDURE
-
Screen of weaning
1\. Screen of weaning is done at 8:00 every morning. 2 If the patient is successful to wean, stop the Dexmedetomidine sedation. 3. If failed to wean, the patient is ventilated again and try to wean after 24 hours, until it is successful to wean and stop sedation,
- DRUG
-
Propofol
Propofol is started with dosage of 0.3 mg/kg/h, observe the patient's response, increase 0.3 mg/kg/h propofol every 10 minutes until target sedation level is obtained(Riker Sedation Agitation Score(SAS) 3-4),then 0.3-3 mg/kg/h propofol is maintained.
- DRUG
-
Midazolam
Midazolam 2 mg is slowly titrated to Riker Sedation Agitation Score(SAS) 3-4 every 10 minutes, then Midazolam 0.02-0.1 mg/kg/h is maintained.
- DRUG
-
Dexmedetomidine
After the screen of the weaning is passed, change to Dexmedetomidine sedation, the dose is 0.2-0.7 mg/kg/h and continuously pumped, increase the dose 0.1-0.2 mg/kg/h every 30 minutes, titrate to Riker Sedation Agitation Score(SAS) 3-4,the maximum dose is 1 mg/kg/h maintained,and prepare for weaning.
Sponsors & Collaborators
-
Chinese Medical Association
collaborator NETWORK -
Tianjin Third Central Hospital
lead OTHER
Principal Investigators
-
Jun Li, Professor · Tianjin Third Central Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-06-30
- Primary Completion
- 2015-04-30
- Completion
- 2015-04-30
More Related Trials
-
Dexmedetomidine Versus Midazolam for Continuous Sedation in the Intensive Care Unit (ICU)
NCT00481312 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Dexmedetomidine Sedation on Delirium and Haemodynamic in Mechanical Ventilated Elderly Patients
NCT02225210 ·Status: UNKNOWN ·Phase: PHASE4
-
The Efficacy and the Safety of Dexmedetomidine Sedation on the Pediatric Intensive Unit(PICU) Patients.
NCT02296073 ·Status: UNKNOWN ·Phase: PHASE4
-
Remifentanil Versus Dexmedetomidine for Post-Cardiac Surgery Patients With Noninvasive Ventilation Intolerance
NCT03395886 ·Status: COMPLETED
-
Dexmedetomidine Versus Propofol in the Medical Intensive Care Unit (MICU)
NCT01059929 ·Status: TERMINATED ·Phase: PHASE4
-
Impacts of Low-Dose Dexmedetomidine on Sleep Quality in Mechanically Ventilated ICU Patients
NCT03335527 ·Status: COMPLETED ·Phase: PHASE4
-
A Safety and Efficacy Study of Dexmedetomidine in ICU Patients Requiring Continuous Sedation
NCT00216190 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Different Sedation and Analgesia Strategies on Patients With Mechanical Ventilation
NCT05024799 ·Status: UNKNOWN ·Phase: PHASE4
-
Impact of Various Sedation Regimens on the Incidence of Delirium
NCT02117726 ·Status: UNKNOWN ·Phase: PHASE4
-
Dexmedetomidine Versus Propofol for Sedation During Awake Endotracheal Intubation
NCT04753515 ·Status: COMPLETED ·Phase: PHASE4
-
Dexmedetomidine Versus Propofol for Prolonged Sedation in Poly Traumatized Mechanically Ventilated Patients
NCT02606409 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Small Doses of Dexmedetomidine for Emergence Agitation
NCT02169843 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of Remifentanil and Dexmedetomidine in Patients With Noninvasive Mechanical Ventilation Intolerance
NCT04734418 ·Status: UNKNOWN ·Phase: NA
-
The Anesthesia Effects of Dexmedetomidine Combined With Desflurane or Propofol in Lobectomy
NCT06207344 ·Status: RECRUITING ·Phase: NA
-
Effects of Dexmedetomidine on Postoperative Cognitive Dysfunction During One-lung Ventilation in Elder Patients
NCT02134093 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effects of Sedative on the Fluid Responsiveness in Critically Ill Patients
NCT01447875 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison the Hemodynamics Effects Between Dexmedetomidine and Propofol in Major Abdominal Surgical Patients
NCT01669044 ·Status: UNKNOWN
-
Pharmacodynamic Interactions of Propofol and Dexmedetomidine on Intravenous Anesthesia
NCT02777619 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Sedative Medications in Patients With Severe Infection and Respiratory Failure
NCT02203019 ·Status: COMPLETED ·Phase: PHASE4
-
Dexmedetomidine for Continuous Sedation
NCT00226785 ·Status: TERMINATED ·Phase: PHASE3
-
Low-dose Dexmedetomidine in Mechanically Ventilated ICU Patients
NCT03172897 ·Status: SUSPENDED ·Phase: PHASE4
-
How Your Patients' Non-REM Sleep Changes On Sedatives in the Intensive Care Units
NCT00826553 ·Status: TERMINATED ·Phase: PHASE1
-
Self-management of Sedative Therapy by Ventilated Patients
NCT02819141 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Night-time Dexmedetomidine-esketamine Infusion and Sleep Quality in ICU Patients
NCT05718024 ·Status: COMPLETED ·Phase: PHASE4
-
Cerebral Vascular Effects of Dexmedetomidine Versus Propofol Sedation in Intubated Mechanically Ventilated ICU Patients
NCT03285165 ·Status: SUSPENDED ·Phase: PHASE2/PHASE3